Metraipolis › archive › dc_574022ee6d37

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease — Europe PMC PMID:41708985

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41708985
DOI
10.1007/s00415-[numero omesso]-7
License (as archived)
solo-consultazione
Archived
2026-11-05T15:59:51.414Z
SHA-256 of the archived text
93eb8b43745beced68a56209ed21fa9fc96bcfe96d6a18819f27fad66fe5cf4d
Stable URL of this page
https://metraipolis.com/documento/dc_574022ee6d37

How to cite

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease — Europe PMC PMID:41708985 — Europe PMC (en), https://europepmc.org/article/MED/41708985 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_574022ee6d37 (Metraipolis archive dc_574022ee6d37, sha256 93eb8b43745beced68a56209ed21fa9fc96bcfe96d6a18819f27fad66fe5cf4d)
BibTeX
@misc{dc574022ee6d37,
  title = {Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease — Europe PMC PMID:41708985},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41708985},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_574022ee6d37; sha256 93eb8b43745beced68a56209ed21fa9fc96bcfe96d6a18819f27fad66fe5cf4d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41708985. Agents can read the archived copy with the MCP tool read_document.